Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CYP17 and breast cancer: no overall effect, but what about interactions?

Breast cancer research : BCR - 1 Jan 2005

Little Julian, Simard Jacques

Abstract excerpt

Three large studies published in recent issues of Breast Cancer Research reported no overall evidence of an association between the CYP17 5'-untranslated region MspA1 polymorphism and breast cancer. The present commentary briefly highlights a few important observations and discusses some additional approaches to further assessment of associations between CYP17 common variants and breast cancer risk. In...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Genetic Predisposition to Disease
Share to Genotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Polymorphism, Single Nucleotide

Share to Risk Factors

Share to Steroid 17-alpha-Hydroxylase

Source

Open in PubMed Open full text

Identifiers

PMID: 16280038
DOI: 10.1186/bcr1320
PMCID: PMC1410734

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CYP17 and breast cancer: no overall effect, but what about interactions?PMID 16280038Read ↗

The CYP17 MspA1 polymorphism and breast cancer risk: a meta-analysis.Semantic proximity Read ↗

CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors.Semantic proximity Read ↗

CYP17 5'-UTR MspA1 polymorphism and the risk of premenopausal breast cancer in a German population-based case-control study.Semantic proximity Read ↗

Lack of association between CYP17 MspA1 polymorphism and breast cancer risk: a meta-analysis of 22,090 cases and 28,498 controls.Semantic proximity Read ↗

CYP17 genotype and breast cancer risk.Semantic proximity Read ↗

Genetic polymorphism of CYP17 and breast cancer risk in Korean women.Semantic proximity Read ↗

CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors: Australian Breast Cancer Family Study.Semantic proximity Read ↗

A systematic review of genetic polymorphisms and breast cancer risk.Semantic proximity Read ↗

CYP17 gene polymorphism in relation to breast cancer risk: a case-control study.Semantic proximity Read ↗

CYP17 and SULT1A1 gene polymorphisms in Indian breast cancer.Semantic proximity Read ↗

Association between CYP17 polymorphisms and the development of breast cancer.Semantic proximity Read ↗

Genetic polymorphisms, the metabolism of estrogens and breast cancer: a review.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.